How long does it take to see the effects of deuterated colexitinib?

Deucravacitinib is an oral, selective TYK2 inhibitor mainly used to treat moderate to severe plaque psoriasis. Its unique mechanism enables it to show good clinical efficacy and safety. So, how long does it take for patients to see obvious therapeutic effects after starting to take deuterated colexitinib?

According to the results of POETYK PSO-1 and PSO-2 clinical trials, deuterated colexitinib demonstrated a faster onset of action in the treatment of psoriasis. In these trials, patients showed significant improvement in skin lesions after 1 week of treatment, and the efficacy was sustained and stable for 52 weeks. This suggests that deuterated colexitinib can be effective in the short term.

In addition, the efficacy of deuterated colexitinib is not only reflected in the improvement of skin lesions, but also includes the improvement of patients' quality of life. In the clinical trials mentioned above, patients experienced significant reductions in skin lesion area and severity, as well as improvements in quality of life scores, further demonstrating the drug's efficacy.

It is important to note that the efficacy of deuterated colexitinib may vary based on individual differences. Some patients may take longer to see significant treatment effects. Therefore, patients should maintain close contact with their doctors while taking deuterated colexitinib, regularly evaluate the treatment effect, and adjust the treatment plan as needed.

In summary, deuterated colexitinib shows a faster onset of action and durable efficacy in the treatment of psoriasis. Patients usually can see obvious therapeutic effects within 1 week after starting treatment, but the specific situation may vary due to individual differences. During the treatment process, patients should maintain close contact with their doctors to ensure the best results of the treatment.

Reference materials:https://go.drugbank.com/drugs/DB16650